Endo Health to acquire Nupathe for $105 million

(Reuters) - Specialty pharmaceutical company Endo Health Solutions Inc said it would buy NuPathe Inc for about $105 million to gain access to NuPathe's migraine treatment, Zecuity. Zecuity, approved by the U.S. Food and Drug Administration in January, is the only FDA-approved prescription migraine patch. Endo said it plans to launch Zecuity in the first half of 2014. The deal is expected to add to Endo's earnings within the first 12 months of closing.



via Health News Headlines - Yahoo News http://news.yahoo.com/endo-health-acquire-nupathe-105-million-125911379--finance.html